Johnson Matthey

About Johnson Matthey

At Johnson Matthey, we work globally with our pharmaceutical customers to deliver complex chemistry solutions for a healthier world. Our world class knowhow, together with our portfolio of catalyst technologies, biocatalysis capabilities, and screening and scale up services, helps to accelerate reactions and optimise processes to make your chemistry more efficient, selective and sustainable.

  • US
  • 2015
    On CPHI since
  • 1
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Primary activities
Agrochemical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Johnson Matthey (4)

  • Cataplatta - Enzyme Screening 96-well Plates

    Product Cataplatta - Enzyme Screening 96-well Plates

    Accelerate your high throughput enzyme screening with Cataplatta 96-well plate enzyme offering
  • Dyad Palladates

    Product Dyad Palladates

    A cost-effective alternative to in situ and advanced cross-coupling systems
  • Enzyme kits

    Product Enzyme kits

    Ready-to-use enzymes for the synthesis of chiral intermediates
  • Catalyst product guide

    Product Catalyst product guide

     Johnson Matthey provides a portfolio of advanced heterogeneous catalysts, homogeneous catalysts and chemocatalysts and biocatalysts for the pharmaceutical market. Our expert technical teams will deliver the solutions you need for more cost effective, efficient and sustainable chemistry.

Johnson Matthey Resources (1)